|
Oct 17
|
Regeneron price target lowered to $1,137 from $1,200 at Truist
|
|
Oct 15
|
Amgen (AMGN) Rises As Market Takes a Dip: Key Facts
|
|
Oct 15
|
AMGEN PRESENTS POSITIVE PHASE 3 DATA FOR UPLIZNA® (INEBILIZUMAB-CDON) IN GENERALIZED MYASTHENIA GRAVIS (GMG) AT AANEM 2024
|
|
Oct 14
|
Why Amgen's Obesity Drug — And $5 Billion Opportunity — Led To A Downgrade
|
|
Oct 14
|
Amgen Seeing Muted Upside Potential for Drug Pipeline, Truist Says
|
|
Oct 14
|
Amgen Stock Falls. The Obesity Drug Landscape Is Getting Crowded.
|
|
Oct 14
|
Amgen Inc. (NASDAQ:AMGN) Delivered A Better ROE Than Its Industry
|
|
Oct 11
|
2 Top Dividend Stocks to Buy Hand Over Fist Right Now
|
|
Oct 10
|
Amgen (AMGN) Dips More Than Broader Market: What You Should Know
|
|
Oct 9
|
2 Biotech Stocks to Buy Hand Over Fist in October
|
|
Oct 8
|
Amgen and MediLink to collaborate on SCLC combination therapy
|
|
Oct 8
|
Want to Invest in the Weight Loss Boom? Consider Buying These 2 Stocks
|
|
Oct 7
|
Insiders At Amgen Sold US$4.0m In Stock, Alluding To Potential Weakness
|
|
Oct 6
|
3 Magnificent Dividend Stocks to Buy in October
|
|
Oct 2
|
Weight loss drug breakthroughs, gene therapies, and more: 8 clinical trials to watch right now
|
|
Oct 1
|
Fresenius Kabi wins FDA approval for Stelara biosimilar Otulfi
|
|
Oct 1
|
LA LA ANTHONY PARTNERS WITH AMGEN TO SHARE CANDID, BEHIND-THE-SCENES LOOK AT HOW PLAQUE PSORIASIS AFFECTS HER LIFE
|
|
Sep 30
|
Amgen must face lawsuit claiming it hid $10.7 billion tax bill
|
|
Sep 30
|
Amgen Inc. (AMGN): Hedge Fund Interest and Strong Pipeline Support Moderate Buy Rating
|
|
Sep 29
|
Institutional investors may overlook Amgen Inc.'s (NASDAQ:AMGN) recent US$7.9b market cap drop as long-term gains remain positive
|